Related Experiment Video
Updated: Feb 10, 2026
03:56
A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
3.0K
Sebo-pharmacokinetics: a proposed percutaneous sebum egression method
Rasika Reddy1, John Havens Cary2, Akram Elmahdy2
1a Dermatology Service , Veterans Affairs Medical Center , San Francisco , CA , USA.
The Journal of Dermatological Treatment
|May 17, 2018
Summary
This study explores drug delivery via the sebaceous gland, crucial for acne treatment. A new method is proposed to quantify drug levels within the gland, advancing sebo-pharmacokinetics research.
Area of Science:
- Dermatology
- Pharmacology
- Skin Biology
Background:
- The sebaceous gland is implicated in acne vulgaris pathogenesis.
- Current acne treatments' drug delivery mechanisms via this gland are poorly understood.
- Percutaneous egression offers a potential route to study drug entry into the skin.
Purpose of the Study:
- To review existing data on drug delivery through the sebaceous gland.
- To propose a method for direct quantification of sebo-pharmacokinetics (PK).
Main Methods:
- Comprehensive literature search across major scientific databases (PubMed, Embase, Google Scholar).
- Inclusion of resources from the UCSF textbook library.
- Analysis of existing studies on sebaceous gland function and drug effects.
Main Results:
- No direct data on sebo-pharmacokinetics (PK) was found.
- Abundant literature exists on pharmacodynamics (PD) of acne treatments.
- Indirect measures of sebaceous gland function are demonstrated in human and hamster models.
Conclusions:
- Current understanding of drug delivery via the sebaceous gland is limited.
- A practical method for direct sebo-PK measurement in humans and animals is proposed.
- This research aims to bridge the gap in understanding drug disposition in the pilosebaceous unit.
Related Concept Videos
01:30Measurement of Bioavailability: Pharmacokinetic Methods
292
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
292
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
547
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
547
01:10Pharmacokinetics: Overview
9.7K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.7K
01:20Pharmacokinetic Models: Overview
2.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.2K
01:19Nonlinear Pharmacokinetics: Overview
1.1K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.1K
01:22Nonlinear Pharmacokinetics: Causes of Nonlinearity
744
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
744